Funding period: January 2025–December 2025
The establishment of this important infrastructure for ME/CFS research was funded by the Federal Ministry of Health (BMG) from 2022 to 2024. The biobank in Munich established a standardised collection of biosamples from patients diagnosed with ME/CFS. It provides a translational basis for the future identification of diagnostic markers, risk factors, new therapeutic approaches and preventive strategies for ME/CFS. The ME/CFS Research Foundation covered the running costs for biosample storage at the TUM Clinical Centre until 2025. The subsequent continued operation is financed through co-operating research projects and new public funding.